J&J’s Tom Frinzi Provides Updates on Innovation Efforts & More

Mitro Opens Up About Aerie’s Programs

Novartis’ Patrick Mooney Gives Inside Look on the Impact of Alcon Spin-Out, Bid to Acquire Xiidra

Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential

Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s Pipeline

Oyster Point Pharma CEO Jeffrey Nau Highlights Details of the Company’s Recent B Round, Ponders IPO

Novaliq’s Bernhard Günther Reveals Company’s Fateful Start, Promising Future for Dry Eye Treatments

What Impact Will Gene Therapy Deals Have on Patients? Start-Ups? Jay Duker, MD, Can Speak for Both.

Wall Street Analyst David Nierengarten of Wedbush Dissects Recent Gene Therapy Shopping Spree

BONUS EPISODE: Direct from OIS@SECO - Industry Leaders Speaking Out on the Optometric Channel